Redburn Atlantic began coverage on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a report issued on Wednesday morning, MarketBeat reports. The firm issued a buy rating and a $195.00 price ...

Shares of Quest Diagnostics Inc. DGX slid 3.78% to $164.18 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 5.97% to 5,074.08 ...

Quest Diagnostics Inc. closed 4.61% short of its 52-week high of $178.87, which the company reached on March 10th.

Quest Diagnostics is Thursday's IBD Stock Of The Day. Shares are lingering in a buy zone, helped by a Texas court's ruling.

Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (NYSE:DGX) with a Buy ...

Redburn Atlantic analyst Jamie Clark initiated coverage of Quest Diagnostics (DGX) with a Buy rating and $195 price target Don't Miss Our End ...

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

Quest Diagnostics (NYSE:DGX – Get Free Report) had its price objective lifted by equities researchers at Robert W. Baird from $190.00 to $191.00 in a note issued to investors on Thursday,Benzinga ...

That said, the brokerage said the fresh AoN is likely to be beneficial for BDL (target price: Rs 1,400), BEL (target price: Rs 350) and Astra Microwave (target price: Rs 935) – all BUYs.

This week, Quest Diagnostics made one of those deals. The diagnostics giant announced a new partnership with Google Cloud that aims to deliver new AI capabilities — including predictive ...

Quest Diagnostics logged a -1.0% change during today's afternoon session, and is now trading at a price of $166.27 per share.